Comorbidity health pathways in heart failure patients: A sequences-of-regressions analysis using cross-sectional data from 10,575 patients in the Swedish Heart Failure Registry
Using cross-sectional data from the Swedish Heart Failure Registry, Claire Lawson and colleagues examine the comorbidity patient-rated health pathways in heart failure patients
Vyšlo v časopise:
Comorbidity health pathways in heart failure patients: A sequences-of-regressions analysis using cross-sectional data from 10,575 patients in the Swedish Heart Failure Registry. PLoS Med 15(3): e32767. doi:10.1371/journal.pmed.1002540
Kategorie:
Research Article
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1002540
Souhrn
Using cross-sectional data from the Swedish Heart Failure Registry, Claire Lawson and colleagues examine the comorbidity patient-rated health pathways in heart failure patients
Zdroje
1. Alpert CM, Smith MA, Hummel SL, Hummel EK. Symptom burden in heart failure: assessment, impact on outcomes, and management. Heart Fail Rev. 2017;22(1):25–39. doi: 10.1007/s10741-016-9581-4 27592330
2. Comin-Colet J, Anguita M, Formiga F, Almenar L, Crespo-Leiro MG, Manzano L, et al. Health-related quality of life of patients with chronic systolic heart failure in Spain: results of the VIDA-IC study. Rev Esp Cardiol (Engl Ed). 2016;69(3):256–71.
3. Lupon J, Gastelurrutia P, De Antonio M, Gonzalez B, Cano L, Cabanes R, et al. Quality of life monitoring in ambulatory heart failure patients: Temporal changes and prognostic value. Eur J Heart Fail. 2013;15(1):103–9. doi: 10.1093/eurjhf/hfs133 22923075
4. Iqbal J, Francis L, Reid J, Murray S, Denvir M. Quality of life in patients with chronic heart failure and their carers: a 3-year follow-up study assessing hospitalization and mortality. Eur J Heart Fail. 2010;12(9):1002–8. doi: 10.1093/eurjhf/hfq114 20615920
5. Joyce E, Chung C, Badloe S, Odutayo K, Desai A, Givertz MM, et al. Variable contribution of heart failure to quality of life in ambulatory heart failure with reduced, better, or preserved ejection fraction. JACC Heart Fail. 2016;4(3):184–93. doi: 10.1016/j.jchf.2015.12.011 26874379
6. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JGF, Coats AJS, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2016;37(27):2129–200. doi: 10.1093/eurheartj/ehw128 27206819
7. Lewis EF. Assessing the impact of heart failure therapeutics on quality of life and functional capacity. Curr Treat Options Cardiovasc Med. 2013;15(4):425–36. doi: 10.1007/s11936-013-0249-2 23625508
8. Rushton CA, Kadam UT. Impact of non-cardiovascular disease comorbidity on cardiovascular disease symptom severity: a population-based study. Int J Cardiol. 2014;175(1):154–61. doi: 10.1016/j.ijcard.2014.05.001 24856803
9. Hamo CE, Heitner JF, Pfeffer MA, Kim HY, Kenwood CT, Assmann SF, et al. Baseline distribution of participants with depression and impaired quality of life in the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial. Circ Heart Fail. 2015;8(2):268–77. doi: 10.1161/CIRCHEARTFAILURE.114.001838 25648577
10. Fujita B, Lauten A, Goebel B, Franz M, Fritzenwanger M, Ferrari M, et al. Impact of diabetes mellitus on quality of life in patients with congestive heart failure. Qual Life Res. 2012;21(7):1171–6. doi: 10.1007/s11136-011-0039-9 22002853
11. Uchmanowicz I, Gobbens RJ. The relationship between frailty, anxiety and depression, and health-related quality of life in elderly patients with heart failure. Clin Interv Aging. 2015;10:1595–600. doi: 10.2147/CIA.S90077 26491276
12. Bohme S, Renneberg B. Predicting self-rated health in diabetes and chronic heart failure—a multiple mediation model. Front Public Health. 2015;3:266. doi: 10.3389/fpubh.2015.00266 26636063
13. Nesbitt T, Doctorvaladan S, Southard JA, Singh S, Fekete A, Marie K, et al. Correlates of quality of life in rural patients with heart failure. Circ Heart Fail. 2014;7(6):882–7. doi: 10.1161/CIRCHEARTFAILURE.113.000577 25146960
14. van Deursen VM, Urso R, Laroche C, Damman K, Dahlström U, Tavazzi L, et al. Co-morbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail. 2014;16(1):103–11. doi: 10.1002/ejhf.30 24453099
15. Jonsson A, Edner M, Alehagen U, Dahlstrom U. Heart failure registry: a valuable tool for improving the management of patients with heart failure. Eur J Heart Fail. 2010;12(1):25–31. doi: 10.1093/eurjhf/hfp175 20023041
16. Wilson I, Cleary P. Linking clinical variables with health-related quality of life: a conceptual model of patient outcomes. JAMA. 1995;273(1):59–65. 7996652
17. Ferrans C, Zerwic J, Wilbur J, Larson J. Conceptual model of health-related quality of life. J Nurs Scholarsh. 2005;37:336–42. 16396406
18. Krethong P, Jirapaet V, Jitpanya C, Sloan R. A causal model of health-related quality of life in Thai patients with heart-failure. J Nurs Scholarsh. 2008;40(3):254–60. doi: 10.1111/j.1547-5069.2008.00235.x 18840209
19. Heo S, Moser DK, Riegel B, Hall LA, Christman N. Testing a published model of health-related quality of life in heart failure. J Card Fail. 2005;11(5):372–9. 15948088
20. Arnold R, Ranchor AV, Koëter GH, de Jongste MJL, Sanderman R. Consequences of chronic obstructive pulmonary disease and chronic heart failure: the relationship between objective and subjective health. Soc Sci Med. 2005;61(10):2144–54. doi: 10.1016/j.socscimed.2005.04.025 15927333
21. Zambroski CH, Moser DK, Bhat G, Ziegler C. Impact of symptom prevalence and symptom burden on quality of life in patients with heart failure. Eur J Cardiovasc Nurs. 2005;4(3):198–206. doi: 10.1016/j.ejcnurse.2005.03.010 15916924
22. Janssen DJ, Spruit MA, Lencer NH, Schols J. Symptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failure. J Palliat Care. 2011;14(6):735–43.
23. Conley S, Feder S, Redeker NS. The relationship between pain, fatigue, depression and functional performance in stable heart failure. Heart Lung. 2017;44(2):107–12.
24. Inkrot S, Lainscak M, Tahirovic E, Trippel TD, Tscholl V, Apostolovic S, et al. Poor self-rated health predicts mortality in patients with stable chronic heart failure. Eur J Cardiovasc Nurs. 2016;15(7):504–12. doi: 10.1177/1474515115615254 26531054
25. Group EuroQol. EuroQol—a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199–208. 10109801
26. Brazier J, Jones N, Kind P. Testing the validity of the Euroqol and comparing it with the SF-36 health survey questionnaire. Qual Life Res. 1993;2(3):169–80. 8401453
27. Dyer M, Goldsmith K, Sharples L, Buxton M. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8:13. doi: 10.1186/1477-7525-8-13 20109189
28. Wermuth N, Sadeghi K. Sequences of regressions and their independences. Test. 2012;21(2):215–52.
29. Konstam V, Moser DK, De Jong MJ. Depression and anxiety in heart failure. J Card Fail. 2005;11(6):455–63. doi: 10.1016/j.cardfail.2005.03.006 16105637
30. van der Wel MC, Jansen RWMM, Bakx JC, Bor HHJ, Olderikkert MGM, van Weel C. Non-cardiovascular co-morbidity in elderly patients with heart failure outnumbers cardiovascular co-morbidity. Eur J Heart Fail. 2007;9(6–7):709–15. doi: 10.1016/j.ejheart.2007.02.004 17395533
31. Krum H, Gilbert RE. Demographics and concomitant disorders in heart failure. Lancet. 2003;362(9378):147–58. doi: 10.1016/S0140-6736(03)13869-X 12867118
32. Shah SJ, Kitzman DW, Borlaug BA, van Heerebeek L, Zile MR, Kass DA, et al. Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap. Circulation. 2016;134(1):73–90. doi: 10.1161/CIRCULATIONAHA.116.021884 27358439
33. Dobre D, de Jongste MJL, Haaijer-Ruskamp F, Sanderman R, van Veldhuisen DJ, Ranchor AV. The enigma of quality of life in patients with heart failure. Int J Cardiol. 2017;125(3):407–9.
34. Jaarsma T, Beattie J, Ryder M, Rutten F, McDonagh T, Mohacsi P, et al. Palliative care in heart failure: a position statement from the palliative care workshop of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2009;11(1):433–43.
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2018 Číslo 3
- Statinová intolerance
- Hydroresponzivní krytí v epitelizační fázi hojení rány
- Parazitičtí červi v terapii Crohnovy choroby a dalších zánětlivých autoimunitních onemocnění
- Metamizol v liečbe pooperačnej bolesti u detí do 6 rokov veku
- Co dělat při intoleranci statinů?
Najčítanejšie v tomto čísle
- Forced anal examinations to ascertain sexual orientation and sexual behavior: An abusive and medically unsound practice
- Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database
- The current and potential health benefits of the National Health Service Health Check cardiovascular disease prevention programme in England: A microsimulation study
- Cardiovascular disease and multimorbidity: A call for interdisciplinary research and personalized cardiovascular care